Загрузка...
Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
Treatment of chronic lymphocytic leukemia (CLL) has advanced with the introduction of chemoimmunotherapy (CIT) agents that have improved the outcomes of frontline therapy. However, most treated patients will relapse and require subsequent therapy. This review focuses on recent advances in the treatm...
Сохранить в:
| Опубликовано в: : | Ann Hematol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Berlin Heidelberg
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5486803/ https://ncbi.nlm.nih.gov/pubmed/28389687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-017-2982-1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|